Continuous pharmaceutical care for patients with type 2 diabetes based on MTM and PCNE classification system
Objective To explore the effect of continuous pharmaceutical care model based on medication therapy management(MTM)and PCNE classification system on the patients with type 2 diabetes mellitus(T2DM).Methods A total of 80 patients with T2DM admitted to Tiemei General Hospital of Liaoning Health Industry Group from January 2022 to May 2022 were selected as the subjects and randomly divided into the control group and the pharmaceutical care group,with 40 in each group.The patients in the control group were treated with traditional medical service mode,while those in the pharmaceutical care group were given pharmaceutical care on the basis of the traditional treatment mode.The illness condition,therapeutic effect,drug compliance and target rate of HbAlc were determined and compared between the two groups.Results Totally 42 problems of treatment effect,7 problems of treatment safety and 2 other problems were found in the pharmaceutical care group during the hospital stay.The main causes included improper drug usage and dosage,inappropriate drug selection and improper course of treatment.The interventions to DRPs included 24 cases for patients and 27 for doctors.After the intervention,38 cases accepted and implemented,6 cases accepted and partially implemented,and 6 cases did not accept.Finally,32 DRPs were solved,9 partially solved and 10 unresolved.The compliance of the patients in the pharmaceutical care group was significantly improved after the discharge,and the compliance rate of HbA1c of the pharmaceutical care group was significantly higher than that of the control group(7.50%(31/40)vs 55.56%(20/36),χ2=6.998,P<0.05).Conclusion Continuous pharmaceutical care carried out for the T2DM patients based on MTM and PCNE classification system can facilitate timely discovery,assessment and solution of DRPs so as to improve the compliance and maintain stable blood glucose of the patients after the discharge.
Type 2 diabetes mellitusPharmaceutical careMedication therapy managementPharmaceutical care network EuropeDrug-related problem
NETL
NSTL
万方数据
